CenExcel acquires Cal company

CenExel Clinical Research Inc. of Salt Lake City, a clinical trial research company, has acquired CTSdatabase, an SaaS firm that provides duplicate clinical trial subject solutions for the healthcare and life science industries. CTSdatabase is located in Sherman Oaks, California.

CTSdatabase not only detects clinical trial subjects who are currently participating in other studies, it can offer the history of a subject’s past study participation and a personalized investigation of actionable matches.

“Adopting CTSdatabase into use throughout the premier CenExel site network reinforces the CenExel promise of high-quality data resulting from each trial,” a CenExel release said.

CTSdatabase will continue to function independently from CenExel, benefiting from shared resources while supporting sites, trials and exclusive sponsor and contract research organizationpartnerships outside of CenExel, the release said.

CTSdatabase will continue to be led by Dr. Thomas M. Shiovitz, a board-certified psychiatrist with over 30 years of clinical research experience. He founded the service to address the substantial negative impacts caused by professional subjects — individuals who attempt to join multiple clinical trials at the same time or otherwise in violation of the trial’s inclusion/exclusion criteria. This behavior skews the reported data and can put these subjects at risk, CenExel said.

“One of the primary and unique capabilities of CTSdatabase is our iterative, algorithm-based technology that allows reporting of diverse, actionable, study-related information on each subject — without access to information that could identify the subject,” said Shiovitz. “We provide optimum levels of privacy and security while remaining efficient and easy to use. We’re excited to join CenExel to support our mission to improve clinical trial data quality.”

“The addition of CTSdatabase elevates the CenExel network promise of quality results for every study we support, across our therapeutic areas of expertise,” said Tom Wardle, CenExel CEO. “This partnership will also provide greater opportunities for CTSdatabase to expand even beyond its impressive current size, growing the registry to include hundreds of thousands more unique subjects within the next few years.”